Fiona E Yull Selected Research

I-kappa B Kinase

7/2010	Conditional ablation of Ikkb inhibits melanoma tumor development in mice.
9/2009	The protein kinase IKKepsilon regulates energy balance in obese mice.
5/2007	Airway epithelium controls lung inflammation and injury through the NF-kappa B pathway.
4/2006	Duration and intensity of NF-kappaB activity determine the severity of endotoxin-induced acute lung injury.
1/2003	Selective I kappa B kinase expression in airway epithelium generates neutrophilic lung inflammation.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Fiona E Yull Research Topics

Disease

26	Neoplasms (Cancer) 05/2022 - 02/2006
14	Inflammation (Inflammations) 01/2022 - 04/2006
14	Pneumonia (Pneumonitis) 01/2020 - 03/2002
9	Carcinogenesis 01/2018 - 03/2007
5	Lung Injury 02/2016 - 04/2006
5	Lung Neoplasms (Lung Cancer) 01/2016 - 11/2007
4	Neoplasm Metastasis (Metastasis) 04/2015 - 01/2008
3	Ovarian Neoplasms (Ovarian Cancer) 05/2022 - 01/2020
3	Lung Diseases (Lung Disease) 04/2016 - 01/2003
3	Melanoma (Melanoma, Malignant) 04/2015 - 07/2010
2	Adenocarcinoma of Lung 01/2018 - 03/2008
2	Insulin Resistance 11/2015 - 09/2009
2	Prostatic Neoplasms (Prostate Cancer) 05/2014 - 08/2008
2	Breast Neoplasms (Breast Cancer) 03/2013 - 03/2007
2	Infections 09/2012 - 01/2010
2	Mastitis 09/2012 - 01/2010
2	Adenocarcinoma 11/2010 - 01/2008
2	Malignant Pleural Effusion 11/2010 - 02/2006
2	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2008 - 11/2007
1	Necrosis 10/2020
1	Noninfiltrating Intraductal Carcinoma (DCIS) 09/2015
1	Communicable Diseases (Infectious Diseases) 04/2015
1	Colonic Neoplasms (Colon Cancer) 04/2015
1	Hyperphagia (Overeating) 01/2015
1	Pancreatic Neoplasms (Pancreatic Cancer) 04/2014
1	Sepsis (Septicemia) 01/2013
1	Hyperplasia 12/2011
1	Interstitial Lung Diseases (Interstitial Lung Disease) 06/2011
1	Fibrosis (Cirrhosis) 06/2011

Drug/Important Bio-Agent (IBA)

23	NF-kappa B (NF-kB)IBA 05/2022 - 01/2003
7	Doxycycline (Periostat)FDA LinkGeneric 10/2020 - 05/2007
6	Transcription Factors (Transcription Factor)IBA 01/2020 - 03/2004
6	Urethane (Ethyl Carbamate)IBA 01/2018 - 11/2007
5	CytokinesIBA 04/2015 - 05/2007
5	I-kappa B KinaseIBA 07/2010 - 01/2003
4	Small Interfering RNA (siRNA)IBA 05/2022 - 03/2013
4	Phosphotransferases (Kinase)IBA 01/2018 - 01/2003
4	LipopolysaccharidesIBA 02/2016 - 03/2009
3	CarcinogensIBA 01/2018 - 04/2012
3	NADPH Oxidases (NAD(P)H oxidase)IBA 05/2013 - 02/2004
3	LuciferasesIBA 09/2012 - 03/2003
3	Proteins (Proteins, Gene)FDA Link 06/2011 - 05/2007
2	Bortezomib (Velcade)FDA Link 01/2016 - 04/2012
2	Oncogene Proteins (Oncogene Protein)IBA 09/2015 - 03/2007
2	Interleukin-5 (Interleukin 5)IBA 04/2015 - 11/2010
2	4- ethoxymethylene- 2- phenyl- 2- oxazoline- 5- one (phOx)IBA 05/2013 - 03/2010
2	NF-KappaB Inhibitor alphaIBA 03/2009 - 03/2004
1	Therapeutic UsesIBA 05/2022
1	Mannose (D-Mannose)IBA 05/2022
1	Neurotransmitter Agents (Neurotransmitter)IBA 01/2022
1	Adenosine Triphosphate (ATP)IBA 01/2022
1	CatalaseIBA 01/2020
1	Heat-Shock Proteins (Heat-Shock Protein)IBA 01/2018
1	Tyrosine Kinase InhibitorsIBA 06/2016
1	ErbB Receptors (EGF Receptor)IBA 06/2016
1	InflammasomesIBA 04/2016
1	Proteasome InhibitorsIBA 01/2016
1	Interleukin-1 Receptors (Interleukin 1 Receptor)IBA 01/2016
1	Glucose (Dextrose)FDA LinkGeneric 11/2015
1	Insulin (Novolin)FDA Link 11/2015
1	Lactic Acid (Lactate)FDA LinkGeneric 11/2015
1	Mucin-1 (CA 15-3 Antigen)IBA 09/2015
1	Folic Acid (Vitamin M)FDA LinkGeneric 07/2015
1	Biological ProductsIBA 04/2015
1	NucleotidesIBA 01/2015
1	Chemokine CCL11IBA 12/2014
1	Histocompatibility Antigens Class IIIBA 12/2014
1	CollagenIBA 04/2014
1	Extracellular Matrix ProteinsIBA 04/2014
1	PeriostinIBA 04/2014
1	LigandsIBA 04/2012
1	ChemokinesIBA 04/2012
1	Proteasome Endopeptidase Complex (Proteasome)IBA 04/2012
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 12/2011
1	Clodronic Acid (Clodronate)IBA 12/2011
1	Liposomes (Liposome)IBA 12/2011
1	Tumor Viral Antigens (Large T Antigen)IBA 08/2011
1	Reactive Oxygen Species (Oxygen Radicals)IBA 08/2011
1	Trans-Activators (Trans-Acting Factor)IBA 08/2011
1	Tetracycline (Achromycin)FDA LinkGeneric 08/2011
1	Bleomycin (Blenoxane)FDA LinkGeneric 06/2011
1	Protein CIBA 06/2011
1	Messenger RNA (mRNA)IBA 06/2011
1	X-Box Binding Protein 1IBA 06/2011
1	Surface-Active Agents (Surfactants)IBA 06/2011
1	Carrier Proteins (Binding Protein)IBA 06/2011
1	TunicamycinIBA 06/2011
1	SmokeIBA 01/2011
1	Histones (Histone)IBA 01/2011
1	Conditioned Culture MediaIBA 11/2010
1	Cyclin-Dependent Kinase 4IBA 07/2010
1	TriterpenesIBA 03/2010
1	Superoxides (Superoxide)IBA 03/2010
1	Oxidants (Oxidizing Agents)IBA 03/2010

Therapy/Procedure

7	Therapeutics 10/2020 - 01/2003
2	Intravenous Injections 04/2015 - 03/2008
1	Immunotherapy 05/2022
1	Radiotherapy 05/2014
1	Ligation 01/2013
1	Punctures 01/2013